Chronic kidney disease (CKD) affects ~10% of the global population, with considerable ethnic
differences in prevalence and aetiology. We assemble genome-wide association studies …

Background COVID-19 counts 46 million people infected and killed more than 1.2 million.
Hypoxaemia is one of the main clinical manifestations, especially in severe cases. HIF1α is a …

AIM: The aim of this study was to compare the efficacy of glimepiride/metformin combination
versus glibenclamide/metformin for reaching glycemic control in patients with uncontrolled …

The organic cation transporters OCT1 and OCT2 and the multidrug and toxin extrusion
transporter MATE1, encoded by the SLC22A1, SLC22A2, and SLC47A1 genes, respectively, are …

Aim: The aim of this study is to describe the percentile distribution of the waist circumference
in Mexican pre‐pubertal children living in an urban, middle‐income area. Methods: Children…

Objectives At the end of 2019, SARS‐CoV‐2 was identified, the one responsible for the
COVID‐19 disease. Between a 5.1% and a 98% of COVID‐19 patients present some form of …

Objective The aim of this study was to evaluate the association between glycemic control (hemoglobin
(Hb) A1c <7%) and the dietary patterns identified in Mexican patients with type 2 …

Context Rare partial/complete loss-of-function mutations in the melanocortin-4 receptor (MC4R)
gene are the most common cause of Mendelian obesity in European populations, but …

Latin America is among the regions with the highest diabetes-related burden. Research and
treatment programs have increased in number and complexity in recent years, but they are …

Chronic kidney disease is a leading cause of death and disability globally and impacts
individuals of African ancestry (AFR) or with ancestry in the Americas (AMS) who are under-…